Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Tolvaptan, ausgenommen Arzneimittel mit einheitlichen Wirkstärken, ATC G04BX21

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2027 · 290 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tolvaptan, ausgenommen Arzneimittel mit einheitlichen Wirkstärken, ATC G04BX21

45/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

45 / 100

Complexity

30 / 100

Risk factors

No estimated contract value or framework maximum is provided. Future revenue depends entirely on actual prescriptions a...

Agreements automatically void if a competitive (open procedure) discount contract for the same active ingredient is con...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Non-exclusive drug discount agreements for Tolvaptan (ATC G04BX21), excluding uniform strengths.
  • Open-house model: any eligible pharmaceutical company can conclude identical, non-negotiable agreements.
Show full summary

Open-house model for non-exclusive drug discount agreements on Tolvaptan (excluding uniform strengths, ATC G04BX21) with AOK Bayern. Any eligible pharmaceutical company can join. Contract term from 01.08.2025 to 31.07.2027, with possible termination. No estimated value provided. Submission via paper or electronic with qualified signature. This is not a standard procurement procedure but a voluntary open-house model.

Risks

No estimated contract value or framework maximum is provided. Future revenue depends entirely on actual prescriptions a...

Agreements automatically void if a competitive (open procedure) discount contract for the same active ingredient is con...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutisches Unternehmen).

Administrative

  • Submit fully signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit signed contract including annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Tolvaptan, ausgenommen Arzneimittel mit einheitlichen Wirkstärken, ATC G04BX21

Open-house model for drug discount agreements on Tolvaptan (excluding uniform strengths). Non-exclusive, identical terms for all participating pharmaceutical companies. Contract duration 01.08.2025 - 31.07.2027.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2025 - Jul 2027

Category

Pharmaceutical products

Deadline

Deadline Jun 03, 2027

Procurement Details

Publication date
15 Jun 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
384847-2025

Documents (2)

Similar tenders